Results 261 to 270 of about 1,826,337 (396)

Impact of 5‐ASA discontinuation in children with ulcerative colitis on biologic therapy: A propensity score‐matched study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives 5‐Aminosalicylic acid (5‐ASA) is recommended as a first‐line medication in mild to moderate ulcerative colitis (UC), but indications regarding its use in children with moderate to severe disease treated with biologics are lacking.
Giulia D'Arcangelo   +12 more
wiley   +1 more source

Impact of Age on Lipid-Lowering Therapy Prescriptions and LDL-Cholesterol Control: Insights from the PORTRAIT-DYS Study. [PDF]

open access: yesGlob Heart
Gavina C   +8 more
europepmc   +1 more source

Programa de monitoramento de defeitos congênitos no Hospital de Clínicas de Porto Alegre : relatório total de 2013

open access: green, 2014
Júlio César Loguercio Leite   +9 more
openalex   +1 more source

Long‐term outcomes of children with ulcerative colitis after acute severe colitis: A GETAID pédiatrique multicenter study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Acute severe colitis (ASC) is a frequent and severe complication of ulcerative colitis (UC) with a high risk of colectomy. Effects of immunosuppressants and anti–tumor necrosis factor (anti‐TNF) agents on the risk of colectomy remain debated. We wished to study the evolution of French pediatric‐onset UC patients after ASC.
Manon Cochet   +18 more
wiley   +1 more source

Protagonismo da enfermagem na criação de um time de PICC adulto no Hospital de Clínicas de Porto Alegre

open access: green, 2017
Vanessa Kenne Longaray   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy